Discover how UBE2E1, a ubiquitin-conjugating enzyme, has emerged as a significant prognostic factor in acute myeloid leukemia, offering new insights into personalized cancer treatment.
Exploring how ubiquitin and ubiquitin-like proteins contribute to Acute Myeloid Leukemia and the promising therapeutic approaches targeting this cellular control system.
Discover how FBXO11 acts as a tumor suppressor in the transformation of MDS to secondary AML, with groundbreaking research revealing its critical role in blood cancer progression.